管理建议,以减少慢性的心脏风险
Trudy D Pang1, Richard L Verrier2, Steven C Schachter3
1Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Epilepsy & behavior reports
|February 20, 2025
概括
患有的成年人面临更高的心血管疾病和过早死亡风险. 本综述概述了管理心脏风险的策略,包括监测和药物审查,以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 临床管理 临床管理
背景情况:
- 慢性与心血管疾病 (CVD) 风险增加和成年人过早心脏死亡有关.
- 病理生理机制包括加速动脉样硬化,心肌梗塞,自主功能障碍,心力衰竭,心律失常和高脂血症.
- 与有关的甲基荷胺激增和缺氧有助于心脏损伤,称为"性心脏".
研究的目的:
- 提供系统的临床管理策略,以减少成人患者心血管疾病风险.
- 突出综合心脏护理在管理中的重要性.
- 为监测和治疗调整提供指导.
主要方法:
- 对和心血管并发症现有文献的综述.
- 建议一个管理战略,包括心血管风险指导方针.
- 强调标准的心电图和心声图监测.
- 建议定期评估血脂质谱.
主要成果:
- 确定与相关的特定心血管风险.
- 承认阻断道的抗发作药物 (ASM) 引起心律失常的风险.
- 承认诱导酶的ASM可以提高血脂水平.
结论:
- 对患者来说,实施心脏风险管理的结构化方法至关重要.
- 需要仔细考虑抗发作药物的心脏影响.
- 最终目标是减轻心脏病风险,减少这一群体的过早死亡率.
相关概念视频
Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
Antiepileptic Drugs: Calcium Channel Blockers
294
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
294
Antiepileptic Drugs: Sodium Channel Blockers
352
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
352
Antiepileptic Drugs: Glutamate Antagonists
271
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
271
Antiepileptic Drugs: Potassium Channel Activators
140
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
140
Antiepileptic Drugs: GABAergic Pathway Potentiators
310
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
310


